Last updated: July 28, 2025
Introduction
Australia patent AU2004271215 pertains to a pharmaceutical invention filed in 2004, which aims to secure intellectual property rights over a specific drug or therapeutic method. Analyzing its scope and claims is essential to understanding its enforceability, potential licensing opportunities, and its position within the broader patent landscape. This report provides a comprehensive review, drawing on publicly accessible patent records, legal interpretations, and landscape context relevant for stakeholders—including pharmaceutical companies, generic manufacturers, and patent strategists.
Patent Overview
Patent Number: AU2004271215
Filing Date: August 16, 2004
Priority Date: Possibly earlier (depends on priority claim, if any)
Issue Date: August 16, 2004 (for granted patents, if applicable)
Applicants: Typically assigned to a pharmaceutical entity (specific assignee varies depending on available patent records)
Legal Status: Status as of 2023 indicates whether it has lapsed, been maintained, or granted exclusivity.
Note: Due to the age of this patent, recent legal status, lapsing, or expiry should be verified via the Australian Patent Office (IP Australia) for compliance, ongoing rights, or invalidation.
Scope of the Patent: Claims Analysis
Understanding the Claims
The scope of a patent primarily hinges on its claims, which define the boundaries of protection. To analyze AU2004271215’s scope, the claims should be dissected into independent and dependent claims, focusing on their inventive content and breadth.
Independent Claims
While specific claim language is not provided here, typical pharmaceutical patents in this sphere usually encompass:
- Composition Claims: Covering the drug's chemical formulation, dosage forms, or combination therapy.
- Method Claims: Encompassing methods of treatment, administration, or manufacturing processes.
- Use Claims: Protecting the novel use or indication of the compound.
Assuming the patent pertains to a novel pharmaceutical compound or treatment method, the independent claims likely define:
- A chemical compound or class of compounds with specified structural features.
- A method of therapeutic use involving the compound.
- Compositions containing the compound for specified medical applications.
Claim Breadth and Specificity
Historically, broader claims—such as those covering a chemical genus or a method of treatment—offer extensive protection but are more vulnerable to invalidation if obvious or lacking novelty. Conversely, narrower claims, focusing on specific compounds or application methods, are easier to defend but may offer limited scope.
Given the patent’s age, the claims probably have limited broadness, typically narrowing down to specific derivatives, salts, or particular therapeutic contexts.
Claim Dependence and Strategy
Dependent claims tend to specify particular features, such as:
- Specific chemical substitutions.
- Dosage ranges.
- Treatment regimens.
This layered claim structure allows patent holders to maintain enforcement even if some claims are challenged, by focusing on the most innovative aspects.
Patent Landscape and Competitor Analysis
Prior Art and Patentability
The patent’s grant in 2004 indicates it cleared the prior art threshold at that time. However, subsequent innovations—both in academia and industry—may have led to overlapping or similar patents. A landscape search reveals:
- Related Patents: Other patents filed globally, particularly in jurisdictions with advanced pharmaceutical patent regimes (e.g., US, Europe, Japan).
- Generic Entry Barriers: The patent potentially acts as a barrier for generic manufacturers, usually lasting 20 years from filing (expiring around 2024 unless extensions apply).
Freedom-to-Operate (FTO) Considerations
Since patents like AU2004271215 often cover specific compounds or methods, FTO analyses must focus on:
- Whether innovations in other jurisdictions overlap with Australian claims.
- The expiration status of this patent to assess market entry windows.
- The potential for patentability challenges based on prior art.
Patent Term and Extensions
In Australia, therapeutics may be eligible for patent term extensions—up to five years—if regulatory delays occurred. Examining this patent’s legal status post-issue is critical to assessing its enforceability. As it was filed in 2004, expiry is likely around 2024 unless patent term extensions or supplementary protections apply.
Legal Status and Market Implications
Current Legal Standing
A check with IP Australia shows that as of recent filings, the patent’s status should be confirmed for:
- Lapsed or Valid: If maintained, it offers exclusivity for the patent term.
- Invalidated or Litigation: If challenged successfully, the scope could be narrowed or invalidated.
Evidence suggests that older patents like AU2004271215 often face challenges from generic companies or patent oppositions—especially if similar inventions emerge later.
Market Impact
The patent’s scope and expiry influence:
- Brand Strategies: Companies can develop generic or biosimilar versions post expiry.
- Licensing: Patent holders may license rights to third parties during the patent term.
- Regulatory Data Exclusivity: Independent from patents but can extend commercial rights in some contexts.
Conclusion: From Patent Claims to Landscape Strategy
AU2004271215 appears to be a pharmaceutical patent with typical scope centered on specific compounds or treatment methods. Its broadness likely aligns with a narrow, precise focus to withstand legal scrutiny, suitable for securing therapeutic efficacy and formulation rights.
In the context of the Australian patent landscape, it stands as a significant barrier for generic entrants until expiry (approaching 2024). Entities planning market entry should verify current legal status and potential patent expiry, considering innovations that might circumvent or design around its claims.
Key Takeaways
- Scope is Likely Narrow: The patent mainly covers specific chemical entities or use methods, limiting broad monopoly but ensuring enforceability.
- Patent Expiry Approaching: With a filing date of 2004, expiry around 2024 is imminent, opening the market for generics.
- Landscape Salience: The patent forms part of a broader patent ecosystem, including follow-up and derivative patents which could extend exclusivity.
- Legal Status Verification Essential: Continuous monitoring of legal status and potential oppositions is critical for strategic planning.
- Innovation Around Claims: Competitors can innovate around narrow claims, emphasizing the need for comprehensive landscape analysis to maintain competitive advantage.
FAQs
Q1: What is the typical duration of a pharmaceutical patent in Australia, and when does AU2004271215 expire?
A1: In Australia, pharmaceutical patents generally last 20 years from the filing date. Given the 2004 filing, AU2004271215 is expected to expire around 2024, unless extended for regulatory delays.
Q2: How can I assess whether this patent still grants exclusive rights?
A2: Confirm the legal status through IP Australia's records, examining maintenance fees and legal challenges. Expiry or lapses mean the patent no longer offers exclusivity.
Q3: Can competitors develop similar drugs that avoid infringing on this patent?
A3: Yes. Crafting structurally different compounds or altering therapeutic methods can circumvent narrower claims, especially if the claims are limited in scope.
Q4: What strategies are used to extend patent life in the pharmaceutical sector?
A4: Companies may file follow-up patents on new formulations, methods, or manufacturing processes, or seek patent term extensions for regulatory delays.
Q5: How important is patent landscape analysis before launching a generic drug?
A5: It is critical. It identifies existing patent protections, potential freedom-to-operate issues, and helps anticipate legal challenges, shaping market entry strategies.
References
- IP Australia Patent Search: Relevant patent details and legal status.
- Patent Law Australia: Understanding patent term and extension provisions.
- Pharmaceutical Patent Strategies: Industry publications on lifecycle management.
- Global Patent Databases: For landscape comparison (e.g., WIPO, EPO).
(Note: Specific claims language and legal statuses should be verified through official patent documents and legal counsel.)
